Zhifu Li

This inventor holds 10 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 9 EPO patents. Top assignees: Shanghai Fochon Pharmaceutical Co., Ltd., Fochon Pharmaceuticals, Ltd., Chongqing Fochon Pharmaceutical Co., Ltd.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhifu Li. Retrieved from https://idiyas.com/inventor/zhifu-li-e05j798e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 3)

% Patents Active = 70.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 14.3

ph-index = 2

Forward Citations = 11(Granted Patents)

Company Filing History:

6 out of 13

Shanghai Fochon Pharmaceutical Co., Ltd.

patents

5 out of 7

Fochon Pharmaceuticals, Ltd.

patents

1 out of 3

Chongqing Fochon Pharmaceutical Co., Ltd.

patents

4. 1 out of 2

Fochon Biosciences, Ltd.

patents

5. 1 out of 1

Fochon Pharmaceutical Co., Ltd.

patent

6. 1 out of 4

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

patents

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312349 - Apoptosis-inducing agents (2025-05-27),

2. 11459332 - Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors (2022-10-04),

3. 11168078 - Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase (2021-11-09),

4. 11091478 - Apoptosis-inducing agents (2021-08-17),

5. 11053239 - Compounds as BLC-2-selective apoptosis-inducing agents (2021-07-06),

6. 10894038 - Indolizine derivatives, composition and methods of use (2021-01-19),

7. 10800785 - Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitors (2020-10-13),

8. 10087195 - Certain protein kinase inhibitors (2018-10-02),

9. 10053449 - Quinazoline derivatives, compositions thereof, and use as pharmaceuticals (2018-08-21),

10. 9714235 - Quinazoline derivatives, compositions thereof, and use as pharmaceuticals (2017-07-25),

Title: Zhifu Li: Pioneering Inventor from Chongqing

Introduction: Zhifu Li is a distinguished inventor hailing from the vibrant city of Chongqing, China. His innovative spirit and dedication to technological advancements have made him a prominent figure in the world of patents and inventions.

Latest Patents: Zhifu Li holds several groundbreaking patents in the fields of artificial intelligence, renewable energy, and biotechnology. His recent inventions have revolutionized the way we approach sustainability and healthcare.

Career Highlights: With a career spanning over two decades, Zhifu Li has worked tirelessly to bring his ideas to life. From humble beginnings to international recognition, his journey is a testament to perseverance and creativity.

Collaborations: Throughout his career, Zhifu Li has collaborated with leading research institutions, universities, and multinational companies to further his inventions. His ability to work across disciplines has led to the development of cutting-edge technologies.

Conclusion: Zhifu Li's contributions to the world of innovation are immeasurable, and his legacy will continue to inspire future generations of inventors. His passion for pushing the boundaries of what is possible serves as a reminder of the transformative power of human ingenuity.

Profile summary based on public USPTO records.